Status | Study |
Active, not recruiting |
Study Name: Corynebacterium Spp Bone and Joint Infection: Retrospective Study of Microbiological, Diagnostic and Therapeutic Features Condition: Corynebacterium Infections Date: 2017-03-09 |
Not yet recruiting |
Study Name: Heterologous Effect of Diptheria, Tetanus, Acellular Pertussis Vaccination on Influenza Challenge in the Elderly Condition: Heterologous Effects of Vaccines Date: 2016-05-03 Interventions: Biological: Seasonal influenza vaccine |
Recruiting |
Study Name: A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil. Condition: Diphtheria Date: 2016-04-28 Interventions: Biological: Combined diphtheria, tetanus and tricomponent acellular pertussis vaccine [Refortrix (Tdap)] |
Completed |
Study Name: Duration of Protection: GSK DTaP Vaccines Condition: Diphtheria Acellular Pertussis Tetanus Date: 2015-03-26 Interventions: Biological: Infanrix Diphtheri |
Recruiting |
Study Name: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women Condition: Diphtheria-Tetanus-acellular Pertussis Vaccines Date: 2015-02-26 Interventions: Biological: Boostrix™ On |
Completed |
Study Name: Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children Condition: Diphtheria Tetanus Acellular Pertussis Date: 2013-11-14 Interventions: Biological: Boostrix™ Single-dose administered intramuscularly in the deltoid region of non-domina |
Completed |
Study Name: Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults Condition: Tetanus Acellular Pertussis Diphtheria Date: 2012-11-21 Interventions: Biological: Boostrix Single dose intramuscular administration. |
Completed |
Study Name: Immunogenicity and Safety Study of Booster Dose of GSK Biologicals' IPV (Poliorix™) and DTPa/Hib (Infanrix+Hib™) Vaccine Condition: Acellular Pertussis Tetanus Diphtheria Date: 2011-10-06 Interventions: Biological: Infanrix+Hib™ |
Completed |
Study Name: Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents Condition: Diphtheria Tetanus Acellular Pertussis Date: 2011-05-19 Interventions: Biological: Boostrix TM (new syringe presentation) |
Completed |
Study Name: Immunogenicity and Reactogenicity Study of BoostrixTM (dTpa) and Boostrix-IPV (dTpa-IPV) Condition: Acellular Pertussis Tetanus Diphtheria Date: 2011-02-10 Interventions: Biological: Boostrix™ (dTpa) |